Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Similar articles for PubMed (Select 8424346)

1.

Acute fracture of the femoral neck: assessment of femoral head perfusion with gadopentetate dimeglumine-enhanced MR imaging.

Lang P, Mauz M, Schörner W, Schwetlick G, Henkes H, Berthezene Y, Grampp S, Jergesen HE, Mühler A, Felix R, et al.

AJR Am J Roentgenol. 1993 Feb;160(2):335-41.

PMID:
8424346
2.

[Early contrast-enhanced MR imaging assessment of femoral head viability after femoral neck fracture].

Cionca D, Alexa O, Leka V.

Rev Med Chir Soc Med Nat Iasi. 2007 Oct-Dec;111(4):959-64. Romanian.

PMID:
18389787
3.

Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.

Jung HW, Chang KH, Choi DS, Han MH, Han MC.

AJR Am J Roentgenol. 1995 Nov;165(5):1251-5.

PMID:
7572513
5.

MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.

van Gils AP, van den Berg R, Falke TH, Bloem JL, Prins HJ, Dillon EH, van der Mey AG, Pauwels EK.

AJR Am J Roentgenol. 1994 Jan;162(1):147-53.

PMID:
8273654
6.

MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.

Vogl TJ, Mack MG, Juergens M, Stark M, Pegios W, Bergman C, Grevers G, Western A.

AJR Am J Roentgenol. 1994 Aug;163(2):425-32.

PMID:
8037044
7.

Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.

Ros PR, Gauger J, Stoupis C, Burton SS, Mao J, Wilcox C, Rosenberg EB, Briggs RW.

AJR Am J Roentgenol. 1995 Dec;165(6):1447-51.

PMID:
7484583
8.

Contrast-enhanced gradient-echo MR imaging of the head and neck: experimental and clinical assessment.

Mihara F, Gupta KL, Joslyn JN.

Radiat Med. 1994 Jul-Aug;12(4):147-51.

PMID:
7809407
9.
10.

Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.

Okizuka H, Sugimura K, Yoshizako T, Kaji Y, Wada A.

J Magn Reson Imaging. 1996 May-Jun;6(3):465-71.

PMID:
8724412
11.

Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas.

Hamed MM, Hamm B, Ibrahim ME, Taupitz M, Mahfouz AE.

AJR Am J Roentgenol. 1992 Feb;158(2):303-7.

PMID:
1729787
12.

Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.

Rofsky NM, Johnson G, Adelman MA, Rosen RJ, Krinsky GA, Weinreb JC.

Radiology. 1997 Oct;205(1):163-9.

PMID:
9314979
13.
14.

MR imaging of Hippel-Lindau disease: value of gadopentetate dimeglumine.

Nelson DR, Yuh WT, Waziri MH, Ryals TJ, Sato Y, Kao SC, Hawes DR, Williams RD.

J Magn Reson Imaging. 1991 Jul-Aug;1(4):469-76.

PMID:
1790370
16.

MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.

Kopka L, Funke M, Fischer U, Keating D, Oestmann J, Grabbe E.

AJR Am J Roentgenol. 1994 Sep;163(3):621-3.

PMID:
8079856
17.

Benign lumbar arachnoiditis: MR imaging with gadopentetate dimeglumine.

Johnson CE, Sze G.

AJNR Am J Neuroradiol. 1990 Jul-Aug;11(4):763-70.

PMID:
2114765
18.

Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.

Low RN, Francis IR, Herfkens RJ, Jeffrey RB Jr, Glazer GM, Foo TK, Shimakawa A, Pelc NJ.

AJR Am J Roentgenol. 1993 Mar;160(3):501-9.

PMID:
8381572
19.

Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.

Fernandez MP, Bernardino ME, Neylan JF, Olson RA.

AJR Am J Roentgenol. 1991 Jun;156(6):1171-6.

PMID:
2028861
20.

MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.

Jensen MC, Brant-Zawadzki M.

AJR Am J Roentgenol. 1993 Jan;160(1):153-7.

PMID:
8416615
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk